Overview

Primary Prevention of Patients With Hepatocellular Carcinoma and Concomitant Esophageal Varices

Status:
Recruiting
Trial end date:
2025-12-31
Target enrollment:
Participant gender:
Summary
Randomized comparison within the endoscopic esophageal varices ligation versus non-selective beta-blocker in the primary prevention of esophageal variceal bleeding in patients with HCC.
Phase:
Phase 4
Details
Lead Sponsor:
Taipei Veterans General Hospital, Taiwan
Treatments:
Propranolol